HP Inc. has named Emma Walmsley as its next Chief Executive Officer, effective 4 January 2027. The appointment was announced on 4 November 2026, after a unanimous decision by HP’s board following what the company called a comprehensive global search. Walmsley succeeds Bruce Broussard, interim CEO since February 2026, who becomes Chair of the Board on the same day. The move is tracked in our Leadership Moves tracker.
Who is Emma Walmsley?
Walmsley is the former chief executive of GSK, where she served as Group CEO from April 2017 through December 2025. She joined GSK in 2010, became CEO of GSK Consumer Healthcare in 2015, and then led the group through a near-nine-year transformation — sharpening its focus on specialty medicines and vaccines, reinvigorating the R&D pipeline, strengthening the balance sheet, and overseeing the separation of the consumer healthcare business.
Before GSK, Walmsley spent 17 years at L’Oréal, building and leading major global consumer businesses. She has also sat on Microsoft’s Board of Directors for seven years — a technology governance credential that matters for the job she is taking.
Why HP picked a pharma chief
HP’s board framed the choice around the AI era. Broussard said HP is “at an important inflection point in technology” and needs a leader who can “build on our innovation heritage and strengths to boldly shape the company’s future” as AI moves to the edge, changing how people work. Walmsley said HP is “an iconic company with a defining role in shaping the future of work on a global scale” and that she would focus on “harnessing the power of the AI era”.
The market’s first verdict was positive: HP shares rose more than 6% on the announcement. Chair Chip Bergh, who has chaired HP’s board since 2017, said Walmsley “stood out for the strength of her leadership experience across multiple industries, the clarity of her strategic thinking and her ability to translate customer insights into new growth”.
What this signals
HP has chosen an outsider with no PC-industry background — and that is the point. Walmsley’s record is transformation at scale: refocusing a sprawling global company, rebuilding its pipeline, and exiting a consumer business to sharpen the core. HP, facing the AI reshaping of personal computing and printing, is buying the same playbook.
The transition is deliberately orderly. Broussard stays on as Chair, giving Walmsley continuity and “valuable guidance”, in Bergh’s words, during the handover and beyond. It is a succession designed to look steady while the strategy changes — a pharma leader, a tech board seat, and a unanimous board behind her.
Related reading: another CEO handover playing out the same season — Hariharan to lead Birlasoft as Guha returns to Wipro.
FAQs
Who is HP’s new CEO? Emma Walmsley, the former CEO of GSK. She takes over as HP Inc.’s Chief Executive Officer on 4 January 2027.
When does Emma Walmsley start at HP? Her appointment takes effect on 4 January 2027, following a unanimous board decision announced on 4 November 2026.
Who was HP’s interim CEO? Bruce Broussard, interim CEO since February 2026. He becomes Chair of the Board on 4 January 2027, succeeding Chip Bergh.